ARID1A and hepatocellular carcinoma: Many findings pointed to a more nuanced involvement for ARID1A in HCC, and distinctive SWI/SNF components can be oncogenic in different scenarios relying on context-specific parameters such as timing, tissue location, existence of collaborating mutations and dosage [140].